AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Novartis to buy generic drug maker.
By James Bernstein, Newsday, Melville, N.Y. Knight Ridder/Tribune Business News
Feb. 22--Eon Labs Inc., one of the larger generic pharmaceutical manufacturers in the metropolitan area, yesterday said it has agreed to be acquired by the giant Swiss drug company Novartis AG, which hopes to become the world's largest producer of low-priced copies of brand-name medicines.
Novartis is also acquiring Eon's parent company, Hexal AG of Germany. Novartis is paying $8.3 billion in the deal. Novartis said it will acquire a majority stake -- 67.7 percent -- in Eon.
Novartis said it will soon begin a tender offer to acquire the rest of Eon for about $1 …
-
- Novartis acquires Hexal and Eon Labs.
-
News wire article from: Asia Africa Intelligence Wire
February 21, 2005
700+ words
-
- Novartis to acquire Hexal AG and Eon Labs, creating the world leader.
-
News wire article from: Europe Intelligence Wire
February 21, 2005
700+ words
-
- Novartis extends tender offer for Eon Labs, Inc. through July 13, 2005.
-
News wire article from: Europe Intelligence Wire
July 5, 2005
700+ words
-
- Novartis extends tender offer for Eon Labs, Inc. through July 1, 2005.
-
News wire article from: Europe Intelligence Wire
June 21, 2005
700+ words
-
- Novartis receives US regulatory approval for completion of Eon Labs acquisition.
-
News wire article from: Europe Intelligence Wire
July 19, 2005
700+ words
